Skip to main content
. 2013 May 24;14:56. doi: 10.1186/1471-2350-14-56

Figure 5.

Figure 5

Relative expression of the SLC26A4 gene in control subjects and in patients with a homozygous mutation of IVS15 + 5G > A or compound heterozygous mutation of IVS15 + 5G > A/H723R. The ratio of SLC26A4 mRNA to GAPDH mRNA is shown in three control subjects (A, B, C), three patients with compound heterozygous mutation of IVS15 + 5G > A/H723R (D, E, F), and three patients with IVS15 + 5G > A homozygous substitution (G, H, I). No expression of SLC26A4 was observed in the three patients with the IVS15 + 5G > A homozygous substitution (G, H, I). All experiments were done in tripricate.